Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 47
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Managing Congenital Adrenal Hyperplasia in the Amish Population

    Congenital adrenal hyperplasia (CAH) is a disorder that affects the production of hormones critical for...

    Can we Measure the Body's Response to Implants by Testing the Blood?

    Would you or a loved one someday benefit from a life-saving medical implant? However, the organisms adapt...

    A Leap Forward to Cure a Neglected Disease

    The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

    Backer Badge Funded